What’s in the DAA?
Two pharmacists share safety risks averted by using every DAA packing check as a mini-medicine review.
Advances in telehealth
Telehealth for pharmacists has been around for some time, but will its expansion during the COVID-19 pandemic era make it normal practice?
Cannabis psychosis risk rises with age
Cannabis use is linked to significantly earlier onset of psychosis, and age is a key factor – found new research from the University of New South Wales.
Meet PSA’s NSW pharmacists of the year
Four outstanding pharmacists were recognised for their dedication to the profession at PSA’s New South Wales Annual Therapeutic Update (ATU) last weekend.
Early elixir: brompheniramine, a first-generation antihistamine
For over 70 years brompheniramine has been used to stifle sneezes … but not for everyone.
SGLT2 inhibitors in heart failure
Heart failure remains a significant health burden, but modern medicines, particularly SGLT2is, can offer significant benefits. Pharmacists play a pivotal role in optimising therapy, ensuring adherence, and providing education to patients.
